PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.33%
Some net income increase while CRON.TO is negative at -252.62%. John Neff would see a short-term edge over the struggling competitor.
2.48%
Some D&A expansion while CRON.TO is negative at -12.59%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-7050.85%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-0.68%
Negative yoy SBC while CRON.TO is 10.97%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-334.41%
Negative yoy working capital usage while CRON.TO is 49.06%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-165.32%
AR is negative yoy while CRON.TO is 35.37%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
37.51%
Inventory shrinking or stable vs. CRON.TO's 237.58%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-173.34%
Negative yoy AP while CRON.TO is 38.49%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
274.57%
Growth well above CRON.TO's 16.38%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-46.49%
Negative yoy while CRON.TO is 3178.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-91.95%
Negative yoy CFO while CRON.TO is 179.13%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-41.11%
Negative yoy CapEx while CRON.TO is 54.06%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-464.10%
Negative yoy acquisition while CRON.TO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
200.00%
Purchases growth of 200.00% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
2885.82%
We have some liquidation growth while CRON.TO is negative at -100.75%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
140.17%
We have some outflow growth while CRON.TO is negative at -332.11%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
409.99%
We have mild expansions while CRON.TO is negative at -104.51%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-607.09%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.